How research can help predict future needs for rare diseases
In Part 2 of our series on rare diseases, Dr. Larry Lynd discusses what the future could look like for the diagnosis and treatment of rare genetic disorders
Read MoreNovember 30, 2021
CHÉOS investigators have been successful at effecting widescale change across health systems at all levels, including internationally. Their work has provided vital data to guide policymakers in transforming existing health infrastructure and making evidence-informed decisions.
In Part 2 of our series on rare diseases, Dr. Larry Lynd discusses what the future could look like for the diagnosis and treatment of rare genetic disorders
Read More
CHÉOS Scientist Dr. Brian Grunau says results from the first peer-reviewed study in North America on COVID-19 mRNA vaccines could inform vaccination policies
Read More
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing
Read More
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read More
In recognition of World Hepatitis Day on July 28, CHÉOS Scientist Dr. Naveed Janjua discusses the BC Hepatitis Testers Cohort
Read More
CHÉOS researchers address unanswered questions to guide policy and resource allocation for chronic disease management
Read More